What aspirin dose is commonly used for suspected ACS in EMS?

• A. 324 mg chewed
• B. 81 mg
• C. 162 mg
• D. 500 mg

Answer: (A)

In suspected ACS, the goal is to rapidly inhibit platelet aggregation to reduce ongoing clot progression. Aspirin does this by irreversibly blocking COX-1, which lowers thromboxane A2 production and prevents platelets from clumping together.

Giving aspirin in a single chewable dose speeds absorption. Chewing increases surface area and allows the drug to enter the bloodstream quickly via the oral mucosa, providing a faster antiplatelet effect than swallowing a tablet whole. In EMS, the emphasis is on a one-time, adequately dosed chewable amount to achieve rapid, reliable platelet inhibition, rather than small daily doses.

Suboptimal options either don’t provide enough rapid platelet inhibition (too small a dose) or add unnecessary risk without extra benefit (much higher doses). So the commonly used approach is a single chewable dose in the high hundreds of milligrams range, chosen to maximize rapid onset while minimizing additional risk.